Pages that link to "Q33895894"
Jump to navigation
Jump to search
The following pages link to Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. (Q33895894):
Displaying 50 items.
- Use of NSAIDs in treating patients with arthritis (Q21195252) (← links)
- 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (Q22306358) (← links)
- Single dose oral lumiracoxib for postoperative pain (Q24242935) (← links)
- Epidemiology and risk profile of heart failure (Q24630778) (← links)
- Tramadol extended-release in the management of chronic pain (Q24654636) (← links)
- Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humans (Q24669542) (← links)
- Adverse effects of spinal manipulation: a systematic review (Q24681683) (← links)
- Harpgophytum procumbens for osteoarthritis and low back pain: a systematic review (Q24795764) (← links)
- Single-dose rofecoxib for acute postoperative pain in adults: a quantitative systematic review (Q24796186) (← links)
- Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports (Q24816687) (← links)
- Non-Steroidal Anti-Inflammatory Drugs and Aspirin Therapy for the Treatment of Acute and Recurrent Idiopathic Pericarditis (Q26749687) (← links)
- Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs (Q27009309) (← links)
- Potent Kinetic Stabilizers That Prevent Transthyretin-Mediated Cardiomyocyte Proteotoxicity (Q27671971) (← links)
- AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin (Q27678369) (← links)
- Nonsteroidal Anti-inflammatory Drugs and Risk of Incident Heart Failure: A Systematic Review and Meta-analysis of Observational Studies (Q28079436) (← links)
- Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO (Q28079515) (← links)
- Cardiovascular prophylaxis with aspirin: costs of supply and management of upper gastrointestinal and renal toxicity (Q28166985) (← links)
- Anticoagulation and heart failure (Q28174940) (← links)
- Doubt and certainty about nonsteroidal anti-inflammatory drugs in the year 2000: a multidisciplinary expert statement (Q28175558) (← links)
- Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study (Q28192227) (← links)
- Relative risk of cardiovascular events in patients with rheumatoid arthritis (Q28192599) (← links)
- Cyclooxygenase inhibition: between the devil and the deep blue sea (Q28192790) (← links)
- Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure? (Q28193462) (← links)
- Association between non-steroid antiinflammatory drugs intake and decompensation of heart failure (Q28196053) (← links)
- Cardiovascular hazard of selective COX-2 inhibitors: myth or reality? (Q28198746) (← links)
- Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice (Q28200864) (← links)
- Cyclo-oxygenase-2 inhibitors: when should they be used in the elderly? (Q28212127) (← links)
- Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk (Q28219220) (← links)
- Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II (Q28508911) (← links)
- Calcium binding-mediated sustained release of minocycline from hydrophilic multilayer coatings targeting infection and inflammation (Q28538368) (← links)
- Faecal blood loss with aspirin, nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors: systematic review of randomized trials using autologous chromium-labelled erythrocytes (Q30481876) (← links)
- Gout and the risk for incident heart failure and systolic dysfunction (Q30505423) (← links)
- Quality of prescribing for the elderly in Croatia-computerized pharmacy data can be used to screen for potentially inappropriate prescribing. (Q30919757) (← links)
- The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months follow-up (Q31013407) (← links)
- Clinical and demographic covariates of chronic opioid and non-opioid analgesic use in rural-dwelling older adults: the MoVIES project (Q33607395) (← links)
- Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks (Q33678007) (← links)
- Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran community (Q33906348) (← links)
- Differences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs: population based study (Q33941101) (← links)
- Cause for concern in the use of non-steroidal anti-inflammatory medications in the community--a population-based study (Q33953093) (← links)
- Systematic review: is the use of NSAIDs effective and safe in the elderly? (Q33973162) (← links)
- Paracetamol: new vistas of an old drug (Q34001974) (← links)
- Rheumatology and musculoskeletal medicine (Q34098905) (← links)
- Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugs (Q34137758) (← links)
- Renal aspects of treatment with conventional nonsteroidal anti-inflammatory drugs versus cyclooxygenase-2-specific inhibitors (Q34137765) (← links)
- Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events. (Q34165559) (← links)
- Optimizing the use of beta-blockers in the effective treatment and management of heart failure: a case study approach (Q34190289) (← links)
- Utilization of potentially inappropriate medications in elderly patients in a tertiary care teaching hospital in India. (Q34221335) (← links)
- Osteoarthritis management: the role of cyclooxygenase-2-selective inhibitors (Q34229075) (← links)
- Pharmacologic management of osteoarthritis-related pain in older adults. (Q34257433) (← links)
- Comorbidity in rheumatoid arthritis. (Q34275967) (← links)